Skip to main content
Top
Published in: Journal of Neuro-Oncology 2/2013

01-06-2013 | Clinical Study

Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and outcome of disease

Authors: Stefano Telera, Alessandra Fabi, Andrea Pace, Antonello Vidiri, Vincenzo Anelli, Carmine Maria Carapella, Laura Marucci, Francesco Crispo, Isabella Sperduti, Alfredo Pompili

Published in: Journal of Neuro-Oncology | Issue 2/2013

Login to get access

Abstract

Sterotactic radiosurgery (SRS) is an effective and commonly employed therapy for metastatic brain tumors. Among complication of this treatment, symptomatic focal cerebral radionecrosis (RN) occurs in 2–10 % of cases. The large diffusion of combined therapies as SRS followed by WBRT and/or CHT, has significantly amplified the number of patients who potentially might be affected by this pathology and neurosurgeons are increasingly called to treat suspected area of RN. Results of surgery of RN in patients with brain metastases are rarely reported in literature, a standardization of diagnostic work-up to correctly identify RN is still lacking and the timing and indications in favour of surgical therapy over medical treatments are not clear as well. In this retrospective study, we review current concept related to RN and analyze the outcome of surgical treatment in a series of 15 patients previously submitted to SRS for brain metastases and affected by suspected radionecrotic lesions. After surgery, all patients except one neurologically improved. No intra-operative complications occurred. Brain edema improved in all patients allowing a reduction or even suspension of corticosteroid therapy. Pure RN was histologically determined in 7 cases; RN and tumor recurrence in the other 8. Overall median survival was 19 months. An aggressive surgical attitude may be advisable in symptomatic patients with suspected cerebral RN, to have histologic confirmation of the lesion, to obtain a long-lasting relief from the mass effect and brain edema and to improve the overall quality of life, sparing a prolonged corticosteroid therapy.
Literature
1.
go back to reference Gavrilovic IT, Posner JB (2005) Brain metastases: epidemiology and pathophysiology. J Neurooncol 75(1):5–14PubMedCrossRef Gavrilovic IT, Posner JB (2005) Brain metastases: epidemiology and pathophysiology. J Neurooncol 75(1):5–14PubMedCrossRef
2.
go back to reference Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G (2006) Stereotactic radiosurgery plus whole brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483–2491PubMedCrossRef Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G (2006) Stereotactic radiosurgery plus whole brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483–2491PubMedCrossRef
3.
go back to reference Bhangoo SS, Linskey ME, Kalkanis SN (2011) Evidence-based guidelines for the management of brain metastases. Neurosurg Clin N Am 22:97–104PubMedCrossRef Bhangoo SS, Linskey ME, Kalkanis SN (2011) Evidence-based guidelines for the management of brain metastases. Neurosurg Clin N Am 22:97–104PubMedCrossRef
4.
go back to reference Karlovits BJ, Quigley MR, Karlovits SM, Miller L, Johnson M, Gayou O, Fuhrer R (2009) Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy. Neurosurg Focus 27(6):E7PubMedCrossRef Karlovits BJ, Quigley MR, Karlovits SM, Miller L, Johnson M, Gayou O, Fuhrer R (2009) Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy. Neurosurg Focus 27(6):E7PubMedCrossRef
5.
6.
go back to reference Kano H, Kondziolka D, Zorro O, Lobato-Polo J, Flickinger JC, Lunsford LD (2009) The results of resection after stereotactic radiosurgery for brain metastases. J Neurosurg 111:825–831PubMedCrossRef Kano H, Kondziolka D, Zorro O, Lobato-Polo J, Flickinger JC, Lunsford LD (2009) The results of resection after stereotactic radiosurgery for brain metastases. J Neurosurg 111:825–831PubMedCrossRef
7.
go back to reference Petrovich Z, Yu C, Giannotta SL, O’Day S, Apuzzo MLJ (2002) Survival pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery. J Neurosurg 97(Suppl 5):499–506PubMed Petrovich Z, Yu C, Giannotta SL, O’Day S, Apuzzo MLJ (2002) Survival pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery. J Neurosurg 97(Suppl 5):499–506PubMed
8.
go back to reference Vidiri A, Guerrisi A, Pinzi V, Fabi A, Mirri MA, Pompili A, Caporale N, Pace A, Crecco M, Marzi S (2012) Perfusion Computed Tomography (PCT) adopting different perfusion metrics: recurrence of brain metastasis or radiation necrosis? Eur J Radiol 81(6):1246–1252PubMedCrossRef Vidiri A, Guerrisi A, Pinzi V, Fabi A, Mirri MA, Pompili A, Caporale N, Pace A, Crecco M, Marzi S (2012) Perfusion Computed Tomography (PCT) adopting different perfusion metrics: recurrence of brain metastasis or radiation necrosis? Eur J Radiol 81(6):1246–1252PubMedCrossRef
9.
go back to reference Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A, Romano A, Maurizi Enrici R (2011) Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 15(6):48CrossRef Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A, Romano A, Maurizi Enrici R (2011) Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 15(6):48CrossRef
10.
go back to reference Friso WA, Hoefnagels FJ, Lagerwaard E, Sanchez E, Haasbeek CJA, Knol DL, Slotman BJ, Vandertop WP (2009) Radiological progression of brain metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence. J Neurol 256:878–887CrossRef Friso WA, Hoefnagels FJ, Lagerwaard E, Sanchez E, Haasbeek CJA, Knol DL, Slotman BJ, Vandertop WP (2009) Radiological progression of brain metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence. J Neurol 256:878–887CrossRef
11.
go back to reference Maldaun MVC, Aguiar PHP, Land F, Suki D, Wildrick D, Sawaya R (2008) Radiosurgery in the treatmeny of brain mestastases: critical review regarding complications. Neurosurg Rev 31:1–9PubMedCrossRef Maldaun MVC, Aguiar PHP, Land F, Suki D, Wildrick D, Sawaya R (2008) Radiosurgery in the treatmeny of brain mestastases: critical review regarding complications. Neurosurg Rev 31:1–9PubMedCrossRef
12.
go back to reference Shöggl A, Kitz K, Reddy M, Wolfsberger St, Schneider B, Dieckmann K, Ungersböck (2000) Defining the role of stereotactic radiosurgery versus microsurgery in the treatment of single brain metastases. Acta Neurochir (Wien) 142:621–626CrossRef Shöggl A, Kitz K, Reddy M, Wolfsberger St, Schneider B, Dieckmann K, Ungersböck (2000) Defining the role of stereotactic radiosurgery versus microsurgery in the treatment of single brain metastases. Acta Neurochir (Wien) 142:621–626CrossRef
13.
go back to reference Yang H, Kano H, Lunsford LD, Niranjan A, Flickinger JC, Kondziolka D (2011) What factors predict the response of larger brain metastases to radiosurgery? Neurosurgery 68:682–690PubMedCrossRef Yang H, Kano H, Lunsford LD, Niranjan A, Flickinger JC, Kondziolka D (2011) What factors predict the response of larger brain metastases to radiosurgery? Neurosurgery 68:682–690PubMedCrossRef
14.
go back to reference Kalkanis SN, Kondziolka D, Gaspar IF, Burri SH, Asher AL, Cobbs CS, Ammirati M, Robinson PD, Andrews DW, Loeffler JS, McDermott M, Mehta MP, Mikkelsen T, Olson JJ, Paleologos NA, Patchell RA, Ryken TC, Lynskey ME (2010) The role of surgical resection in the management of newly diagnosed brain metastases: a systemic review and evidence-based clinical practice guideline. J Neurooncol 96:33–43PubMedCrossRef Kalkanis SN, Kondziolka D, Gaspar IF, Burri SH, Asher AL, Cobbs CS, Ammirati M, Robinson PD, Andrews DW, Loeffler JS, McDermott M, Mehta MP, Mikkelsen T, Olson JJ, Paleologos NA, Patchell RA, Ryken TC, Lynskey ME (2010) The role of surgical resection in the management of newly diagnosed brain metastases: a systemic review and evidence-based clinical practice guideline. J Neurooncol 96:33–43PubMedCrossRef
15.
go back to reference Dequesada IM, Quisling RG, Yachnis A, Friedman WA (2008) Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? Neurosurgery 63:898–904PubMedCrossRef Dequesada IM, Quisling RG, Yachnis A, Friedman WA (2008) Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? Neurosurgery 63:898–904PubMedCrossRef
16.
go back to reference Ruben JD, Dally M, Bailey M, Smith R, McLean CA, Fedele P (2006) Cerebral radiation necrosis: incidence, outcomes, and risk fctors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys 65:499–508PubMedCrossRef Ruben JD, Dally M, Bailey M, Smith R, McLean CA, Fedele P (2006) Cerebral radiation necrosis: incidence, outcomes, and risk fctors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys 65:499–508PubMedCrossRef
17.
go back to reference Carangelo B, Cerillo A, Mariottini A, Peri G, Rubino G, Mourmouras V, Palma L, Antenore S (2010) Therapeutic strategy of late cerebral radionecrosis: a retrospective study of 21 cases. J Neurosurg Sci 54:21–28PubMed Carangelo B, Cerillo A, Mariottini A, Peri G, Rubino G, Mourmouras V, Palma L, Antenore S (2010) Therapeutic strategy of late cerebral radionecrosis: a retrospective study of 21 cases. J Neurosurg Sci 54:21–28PubMed
18.
go back to reference Wong ST, Loo KT, Yam KY, Hung WM, Fok KF, Yuen SC, Fong D (2010) Results of excision of cerebral radionecrosis: experience in patients treated with radiation therapy for nasopharyngeal carcinoma. J Neurosurg 113:293–300PubMedCrossRef Wong ST, Loo KT, Yam KY, Hung WM, Fok KF, Yuen SC, Fong D (2010) Results of excision of cerebral radionecrosis: experience in patients treated with radiation therapy for nasopharyngeal carcinoma. J Neurosurg 113:293–300PubMedCrossRef
20.
go back to reference Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC (2010) Irradiated volume as predictor of brain radiosurgery after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 77(4):996–1001PubMedCrossRef Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC (2010) Irradiated volume as predictor of brain radiosurgery after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 77(4):996–1001PubMedCrossRef
21.
go back to reference Marks JE, Baglan RJ, Prassad SC, Blank WF (1981) Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume. Int J Radiat Oncol Biol Phys 17:243–252CrossRef Marks JE, Baglan RJ, Prassad SC, Blank WF (1981) Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume. Int J Radiat Oncol Biol Phys 17:243–252CrossRef
23.
go back to reference Torcuator R, Zuniga R, Mohan YS, Rock J, Doyle T, Anderson J, Gutierrez J, Ryu S, Jain R, Rosenblum M, Mikkelsen (2009) Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol 94(1):63–68PubMedCrossRef Torcuator R, Zuniga R, Mohan YS, Rock J, Doyle T, Anderson J, Gutierrez J, Ryu S, Jain R, Rosenblum M, Mikkelsen (2009) Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol 94(1):63–68PubMedCrossRef
24.
go back to reference Truong MT, St Clair EG, Donahue BR, Rush SC, Miller DC, Formenti SC, Knopp EA, Han K, Golfinos JG (2006) Results of surgical resection for progression of brain metastases previously treated by gamma-knife radiosurgery. Neurosurgery 59:86–97PubMedCrossRef Truong MT, St Clair EG, Donahue BR, Rush SC, Miller DC, Formenti SC, Knopp EA, Han K, Golfinos JG (2006) Results of surgical resection for progression of brain metastases previously treated by gamma-knife radiosurgery. Neurosurgery 59:86–97PubMedCrossRef
25.
go back to reference Williams BJ, Suki D, Fox B, Pelloski CE, Maldaun MVC, Sawaya RE, Lang FF, Rao G (2009) Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications. J Neurosurg 111:439–448PubMedCrossRef Williams BJ, Suki D, Fox B, Pelloski CE, Maldaun MVC, Sawaya RE, Lang FF, Rao G (2009) Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications. J Neurosurg 111:439–448PubMedCrossRef
26.
go back to reference Kjellberg RN (1979) Isoeffective dose parameters for brain necrosis in relation to proton radiosurgical dosimetry. In Szilka G (ed). Sterotactic cerebral irradiation. INSERM symposium, vol 12. Elsevier Press, Amsterdam, p 157–166 Kjellberg RN (1979) Isoeffective dose parameters for brain necrosis in relation to proton radiosurgical dosimetry. In Szilka G (ed). Sterotactic cerebral irradiation. INSERM symposium, vol 12. Elsevier Press, Amsterdam, p 157–166
27.
go back to reference Flickinger JC, Schell MC, Larson DA (1990) Estimation of complications for linear accelerator radiosurgery with integrated logistic formula. Int J Radiat Oncol Biol Phys 19:143–148PubMedCrossRef Flickinger JC, Schell MC, Larson DA (1990) Estimation of complications for linear accelerator radiosurgery with integrated logistic formula. Int J Radiat Oncol Biol Phys 19:143–148PubMedCrossRef
28.
go back to reference Shehata MK, Young B, Reid B, Patchell RA, St Clair W, Sims J, Sanders M, Meigooni A, Mohiuddin M, Regine W (2004) Stereotactic Radiosurgery of 468 brain metastases ≤ 2 cm: implications for SRS dose and whole brain radiation therapy. Int J Radiation Oncol Biol Phys 59(1):87–93CrossRef Shehata MK, Young B, Reid B, Patchell RA, St Clair W, Sims J, Sanders M, Meigooni A, Mohiuddin M, Regine W (2004) Stereotactic Radiosurgery of 468 brain metastases ≤ 2 cm: implications for SRS dose and whole brain radiation therapy. Int J Radiation Oncol Biol Phys 59(1):87–93CrossRef
29.
go back to reference Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952–26001 study. J Clin Oncol 29:134–141PubMedCrossRef Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952–26001 study. J Clin Oncol 29:134–141PubMedCrossRef
30.
go back to reference Swinson BM, Friedman WA (2008) Linear accelerator stereotactic radiosurgery for metastatic brain tumors: 17 years of experience at the University of Florida. Neurosurgery 62:1018–1032PubMedCrossRef Swinson BM, Friedman WA (2008) Linear accelerator stereotactic radiosurgery for metastatic brain tumors: 17 years of experience at the University of Florida. Neurosurgery 62:1018–1032PubMedCrossRef
31.
go back to reference Stockham AL, Suh JH, Chao ST, Barnett GH (2012) Management of recurrent brain metastases after radiosurgery. Prog Neurol Surg 25:273–285PubMedCrossRef Stockham AL, Suh JH, Chao ST, Barnett GH (2012) Management of recurrent brain metastases after radiosurgery. Prog Neurol Surg 25:273–285PubMedCrossRef
32.
go back to reference Safdari H, Fuentes JM, Dubois JB, Alirezai M, Castan P, Vlahovitch B (1985) Radiation necrosis of the brain: time of onset and incidence related to a total dose and fractionation of radiation. Neuroradiology 27:44–47PubMedCrossRef Safdari H, Fuentes JM, Dubois JB, Alirezai M, Castan P, Vlahovitch B (1985) Radiation necrosis of the brain: time of onset and incidence related to a total dose and fractionation of radiation. Neuroradiology 27:44–47PubMedCrossRef
33.
go back to reference Bindal RK, Sawaya R, Leavens ME, Hess KR, Taylor SH (1995) Reoperation for recurrent metastatic brain tumors. J Neurosurg 83:600–604PubMedCrossRef Bindal RK, Sawaya R, Leavens ME, Hess KR, Taylor SH (1995) Reoperation for recurrent metastatic brain tumors. J Neurosurg 83:600–604PubMedCrossRef
34.
go back to reference Molenaar R, Wiggenraad R, Verbeek-de Kanter A, Walchenbach R, Vecht C (2009) Relationship between volume, dose, and local control in stereotactic radiosurgery of brain metastasis. Br J Neurosurg 23(2):170–178PubMedCrossRef Molenaar R, Wiggenraad R, Verbeek-de Kanter A, Walchenbach R, Vecht C (2009) Relationship between volume, dose, and local control in stereotactic radiosurgery of brain metastasis. Br J Neurosurg 23(2):170–178PubMedCrossRef
35.
go back to reference Foroughi M, Kemeny Lehecka M, Wons J, Kajidi L, Hatfield R, Marks S (2010) Operative intervention for delayed symptomatic radionecrotic masses developing following stereotactic radiosurgery for cerebral arteriovenous malformations-case analysis and literature review. Acta Neurochir 152:803–815PubMedCrossRef Foroughi M, Kemeny Lehecka M, Wons J, Kajidi L, Hatfield R, Marks S (2010) Operative intervention for delayed symptomatic radionecrotic masses developing following stereotactic radiosurgery for cerebral arteriovenous malformations-case analysis and literature review. Acta Neurochir 152:803–815PubMedCrossRef
36.
go back to reference Vecil GG, Suki D, Muldaun MV, Lang FF, Sawaya R (2005) Resection of brain metastases previously treated with stereotactic radiosurgery. J Neurosurg 102:209–215PubMedCrossRef Vecil GG, Suki D, Muldaun MV, Lang FF, Sawaya R (2005) Resection of brain metastases previously treated with stereotactic radiosurgery. J Neurosurg 102:209–215PubMedCrossRef
37.
go back to reference Korytko T, Radivoyevitch T, Colussi V, Wessels BW, Pillai K, Maciunas RJ, Einstein DB (2006) 12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors. Int J Radiat Oncol Biol Phys 64:419–424PubMedCrossRef Korytko T, Radivoyevitch T, Colussi V, Wessels BW, Pillai K, Maciunas RJ, Einstein DB (2006) 12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors. Int J Radiat Oncol Biol Phys 64:419–424PubMedCrossRef
38.
go back to reference Ohtakara K, Hayashi S, Nakayama N, Ohe N, Yano H, Iwama T, Hoshi H (2012) Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after multileaf collimator-based stereotactic radiosurgery for brain metastases. J Neurooncol 108:201–209PubMedCrossRef Ohtakara K, Hayashi S, Nakayama N, Ohe N, Yano H, Iwama T, Hoshi H (2012) Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after multileaf collimator-based stereotactic radiosurgery for brain metastases. J Neurooncol 108:201–209PubMedCrossRef
39.
go back to reference Szeifert GT, Massager N, DeVriendt D, David D, De Smedt F, Rorive Salmon I, Brotchi J, Levivier M (2002) Observations of intracranial neoplasms treated with gamma knife radiosurgery. J Neurosurg 97:623–626PubMed Szeifert GT, Massager N, DeVriendt D, David D, De Smedt F, Rorive Salmon I, Brotchi J, Levivier M (2002) Observations of intracranial neoplasms treated with gamma knife radiosurgery. J Neurosurg 97:623–626PubMed
40.
go back to reference Coderre JA, Morris GM, Micca PL, Hopewell JW, Verhagen I, Kleiboer BJ, van der Kogel AJ (2006) Late effects of radiation on the central nervous system: role of vascular endothelial damage and glial stem cell survivor. Radiat Res 166:495–503PubMedCrossRef Coderre JA, Morris GM, Micca PL, Hopewell JW, Verhagen I, Kleiboer BJ, van der Kogel AJ (2006) Late effects of radiation on the central nervous system: role of vascular endothelial damage and glial stem cell survivor. Radiat Res 166:495–503PubMedCrossRef
41.
go back to reference Barajas RF, Chang JS, Sneed PK, Segal MR, McDermott MW, Cha S (2009) Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR 30:367–372PubMedCrossRef Barajas RF, Chang JS, Sneed PK, Segal MR, McDermott MW, Cha S (2009) Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR 30:367–372PubMedCrossRef
43.
go back to reference Ross DA, Sandler HM, Balter JM et al (2002) Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors. J Neurooncol 56:175–182PubMedCrossRef Ross DA, Sandler HM, Balter JM et al (2002) Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors. J Neurooncol 56:175–182PubMedCrossRef
44.
go back to reference Belohlavek O, Simonova G, Kantorova I, Novotny J Jr, Liscak R (2003) Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumor progression? Eur J Nucl Med Mol Imaging 30(1):96–100PubMedCrossRef Belohlavek O, Simonova G, Kantorova I, Novotny J Jr, Liscak R (2003) Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumor progression? Eur J Nucl Med Mol Imaging 30(1):96–100PubMedCrossRef
45.
go back to reference Jain R, Narang J, Sundgren PM, Hearshen D, Saksena S, Rock JP, Gutierrez J, Mikkelsen (2010) Treatment induced necrosis versus recurrent/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging. J Neurooncol 100:17–29PubMedCrossRef Jain R, Narang J, Sundgren PM, Hearshen D, Saksena S, Rock JP, Gutierrez J, Mikkelsen (2010) Treatment induced necrosis versus recurrent/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging. J Neurooncol 100:17–29PubMedCrossRef
46.
go back to reference Gonzalez J, Kumar AJ, Conrad CA, Levin VA (2007) Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 67:323–326PubMedCrossRef Gonzalez J, Kumar AJ, Conrad CA, Levin VA (2007) Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 67:323–326PubMedCrossRef
47.
go back to reference Ammirati M, Cobbs CS, Linskey ME, Paleologos NA, Ryken TC, Burri SH, Asher AL, Loeffler JS, Robinson PD, Andrews DW, Gaspar LE, Kondziolka D, McDErmott M, Mehta MP, Mikkelsen T, Olson JJ, Patchell RA, Kalkanis SN (2010) The role of retreatment in the management of recurrent/progressive brain metastases: a systemic review and evidence-based clinical practice guidelines. J Neurooncol 96:85–96PubMedCrossRef Ammirati M, Cobbs CS, Linskey ME, Paleologos NA, Ryken TC, Burri SH, Asher AL, Loeffler JS, Robinson PD, Andrews DW, Gaspar LE, Kondziolka D, McDErmott M, Mehta MP, Mikkelsen T, Olson JJ, Patchell RA, Kalkanis SN (2010) The role of retreatment in the management of recurrent/progressive brain metastases: a systemic review and evidence-based clinical practice guidelines. J Neurooncol 96:85–96PubMedCrossRef
48.
go back to reference Gaspar LE, Scott C, Murray K, Curran W (2000) Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47(4):1001–1006PubMedCrossRef Gaspar LE, Scott C, Murray K, Curran W (2000) Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47(4):1001–1006PubMedCrossRef
49.
go back to reference Narang J, Jain R, Arbab AS, Mikkelsen T, Scarpace L, Rosenblum ML, Hearschen D, Babajani-Feremi A (2011) Differentiating treatment-induced radionecrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion. Neuro Oncol 13(9):1037–1046PubMedCrossRef Narang J, Jain R, Arbab AS, Mikkelsen T, Scarpace L, Rosenblum ML, Hearschen D, Babajani-Feremi A (2011) Differentiating treatment-induced radionecrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion. Neuro Oncol 13(9):1037–1046PubMedCrossRef
50.
go back to reference McPherson C, Warnick R (2004) Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging. J Neurooncol 68(1):41–47PubMedCrossRef McPherson C, Warnick R (2004) Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging. J Neurooncol 68(1):41–47PubMedCrossRef
Metadata
Title
Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and outcome of disease
Authors
Stefano Telera
Alessandra Fabi
Andrea Pace
Antonello Vidiri
Vincenzo Anelli
Carmine Maria Carapella
Laura Marucci
Francesco Crispo
Isabella Sperduti
Alfredo Pompili
Publication date
01-06-2013
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 2/2013
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-013-1120-8

Other articles of this Issue 2/2013

Journal of Neuro-Oncology 2/2013 Go to the issue